Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Mavenclad
Pharma
Merck KGaA, analysts share optimism about potential CDMO rebound
After a rocky start to the year, Merck KGaA’s CDMO and process solutions units appear to be nearing a comeback.
Fraiser Kansteiner
Aug 7, 2024 3:13pm
After pulling Lumoxiti in Europe, AstraZeneca does same in US
Jan 13, 2023 10:15am
Merck KGaA launches first-ever TV ad for MS med Mavenclad
Jul 19, 2021 7:32am
Merck KGaA's new chief rejigs its U.S. management team
May 18, 2021 11:39am
The top 20 most expensive pharmacy drugs in the U.S. in 2021
Mar 9, 2021 12:12pm
Merck KGaA partners with social gaming platform Twitch for MS
Jun 8, 2020 10:15am
